Literature DB >> 15965966

A high predisposition to depression and anxiety in mothers and other matrilineal relatives of children with presumed maternally inherited mitochondrial disorders.

Richard G Boles1, Brittany B Burnett, Katrina Gleditsch, Stacey Wong, Ariela Guedalia, Anneli Kaariainen, Judy Eloed, Alan Stern, Virdette Brumm.   

Abstract

Although mothers of chronically ill children are generally prone to depression and anxiety, clinical observation suggests that these symptoms are relatively increased in mothers of children with maternally inherited mitochondrial disorders (MIMD). In this study, the Beck Depression Inventory II (BDI), the Beck Anxiety Inventory (BAI), and a non-standardized mental health questionnaire were administered to 15 mothers of children with MIMD and 17 mothers of children with autosomal recessive metabolic disorders (ARMD) followed in one clinic. One half of the children in both groups suffer from mental retardation and/or > or = 2 hospitalizations/year related to their genetic disorder, and were labeled as severely affected. BDI and BAI scores were similar between mothers of severely affected MIMD and ARMD children, but BDI and BAI scores were threefold higher in mothers of mildly affected MIMD versus ARMD children (P = 0.001 and P = 0.003, respectively). Any mental health condition was self-reported in 10/15 MIMD and 2/17 ARMD mothers (P = 0.002), while at least one mental health condition per family was reported to be present in a matrilineal first-degree relative of the mother in 8/15 MIMD versus 1/17 ARMD families (P = 0.004). Our data confirm that mental health conditions, particularly depression, are diagnosed at an increased frequency among matrilineal relatives likely sharing the same mitochondrial DNA (mtDNA) as the affected proband. While previous studies have demonstrated that mtDNA sequences can affect brain function, our data suggests that in addition mtDNA sequences can predispose individuals towards the development of some "mental health" disorders. Thus, "genome-wide" studies to screen for genes associated with depression and anxiety should not neglect the small, yet important, mitochondrial genome. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15965966     DOI: 10.1002/ajmg.b.30199

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  9 in total

Review 1.  Mitochondrial regulation of neuronal plasticity.

Authors:  Mark P Mattson
Journal:  Neurochem Res       Date:  2006-10-06       Impact factor: 3.996

Review 2.  A mitochondrial bioenergetic basis of depression.

Authors:  N Jennifer Klinedinst; William T Regenold
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

Review 3.  Sex-dependent mental illnesses and mitochondria.

Authors:  Akiko Shimamoto; Virginie Rappeneau
Journal:  Schizophr Res       Date:  2017-03-06       Impact factor: 4.939

Review 4.  Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications.

Authors:  Tadafumi Kato
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

5.  Oxidative metabolism alterations in the emotional brain of anxiety-prone rats.

Authors:  Chelsea R McCoy; Mohammad N Sabbagh; Jonathan P Huaman; Alicia M Pickrell; Sarah M Clinton
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-07-19       Impact factor: 5.067

Review 6.  Impaired mitochondrial function in psychiatric disorders.

Authors:  Husseini Manji; Tadafumi Kato; Nicholas A Di Prospero; Seth Ness; M Flint Beal; Michael Krams; Guang Chen
Journal:  Nat Rev Neurosci       Date:  2012-04-18       Impact factor: 34.870

Review 7.  Sex differences in anxiety and emotional behavior.

Authors:  Nina C Donner; Christopher A Lowry
Journal:  Pflugers Arch       Date:  2013-04-16       Impact factor: 3.657

8.  Symptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression.

Authors:  Ann Gardner; Richard G Boles
Journal:  Biopsychosoc Med       Date:  2008-02-22

Review 9.  Creatine for the Treatment of Depression.

Authors:  Brent M Kious; Douglas G Kondo; Perry F Renshaw
Journal:  Biomolecules       Date:  2019-08-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.